ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,150, issued on April 22, was assigned to CARTHERICS Pty LTD. (Carlton, Australia).
"T cell disease treatment targeting TAG-72" was invented by Vera Evtimov (Carlton, Australia), Richard Boyd (Carlton, Australia), Ian Nisbet (Carlton, Australia), Miles Prince (Carlton, Australia) and Alan Trounson (Carlton, Australia).
According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to treatment of T cell diseases, particularly T cell lymphomas (TCLs) including, in particular, cutaneous T cell lymphomas (CTCLs) such as Sezary Syndrome (SS) and mycosis fungoides (MF), by targeting tumor-associated glycoprotein-72 (TAG-72)."
The patent was filed on...